Related Experiment Video
Updated: Jun 20, 2026
07:34
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Cardiac disease in pregnancy.
Ruth Curry1, Lorna Swan, Philip J Steer
1Academic Department of Obstetrics and Gynaecology, Imperial College London, Chelsea and Westminster Hospital, London SW10 9NH, UK.
Current Opinion in Obstetrics & Gynecology
|September 26, 2009
Summary
Cardiac disease in pregnancy is a growing concern, with a five-fold increase in maternal mortality. Advances in treatment for acquired and congenital heart conditions have improved outcomes, particularly for ischemic heart disease and pulmonary hypotension.
Area of Science:
- Cardiology
- Maternal Health
- Public Health
Background:
- Maternal mortality due to acquired heart disease has increased five-fold in the UK over 15 years.
- Surgical advances for congenital heart disease allow more women to reach childbearing age.
Purpose of the Study:
- To review the increasing incidence and management of cardiac conditions in pregnant women.
- To update readers on critical advancements in cardiovascular care during pregnancy.
Main Methods:
- Literature review focusing on recent findings in maternal cardiology.
- Analysis of trends in acquired and congenital heart disease impacting pregnancy.
Main Results:
- Acute myocardial infarction incidence is rising, linked to older maternal age and obesity.
- Percutaneous coronary intervention with stenting is the preferred treatment for acute myocardial infarction.
- Improved management of pulmonary vascular disease, including sildenafil use, has reduced mortality.
- Endocarditis prophylaxis is now reserved for highest-risk cases.
Conclusions:
- Cardiac disease in pregnancy is a significant and growing concern for maternal health.
- Care improvements are notable in ischemic heart disease and pulmonary hypotension management.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...